Navigation Links
Radient Pharmaceuticals Corporation Joins OTCQX
Date:6/23/2011

NEW YORK, June 23, 2011 /PRNewswire/ -- OTC Markets Group Inc. (OTCQX: OTCM), the company that operates the world's largest electronic marketplace for broker-dealers to trade unlisted stocks, today announced that Radient Pharmaceuticals Corporation (OTCQX: RXPC), the developer and worldwide marketer of the Onko-Sure® non-invasive cancer blood test kit, has qualified to trade on the OTC market's highest tier, OTCQX®.

(Logo: http://photos.prnewswire.com/prnh/20110118/MM31963LOGO)

"Radient Pharmaceuticals has chosen to remain investor-focused as they transition to trade on OTCQX, which allows them to continue to provide superior information and transparent trading on the quality-controlled OTCQX platform," said R. Cromwell Coulson, President and Chief Executive Officer of OTC Markets Group. "We are pleased to welcome Radient Pharmaceuticals to OTCQX."

Radient Pharmaceuticals began trading today on the OTC market's prestigious tier, OTCQX U.S. Premier. Investors can find current financial disclosure and Real-Time Level 2 quotes for the Company on www.otcqx.com and www.otcmarkets.com.

"In moving to OTCQX, we will continue to deliver liquidity, transparency, and an efficient market for our shareholders while reducing the financial and management resources required for an exchange listing," Douglas MacLellan, CEO of Radient Pharmaceuticals. "We are moving forward, dedicating more time and resources to the execution of our core business delivering high-value cancer diagnostics to the global healthcare system."

Merriman Capital, Inc. will serve as Radient Pharmaceuticals' Designated Advisor for Disclosure ("DAD") on OTCQX, responsible for providing guidance on OTCQX requirements.

About Radient Pharmaceuticals

<
'/>"/>
SOURCE OTC Markets Group Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Use of PressureWire(R) Yields a More Accurate Assessment of Translesion Pressure Gradients in Peripheral Vasculature, Two New Studies Report
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
6. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
7. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
8. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
9. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
10. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
11. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... DIEGO , July 30, 2015  Tandem ... medical device company and manufacturer of the t:slim® ... has entered into non-exclusive Development Agreements with Dexcom, ... Tandem insulin pumps with the Dexcom G5 and ... "Integrating Tandem,s next generation pump platform with Dexcom,s ...
(Date:7/30/2015)... and VANCOUVER , July ... ) announced today that it will report its second ... Company management will host a conference call and live ... overview of financial results, clinical development programs and a ... webcast, log on to the Investor Relations page of ...
(Date:7/30/2015)... , July 30, 2015 Tianyin Pharmaceutical Inc. ... company that specializes in the patented biopharmaceutical, modernized traditional ... (API), provided updates regarding the notice it received on ... "Exchange") indicating that the Company was below certain of ... Sections 134 and 1101 of the NYSE MKT Company ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 2Tandem Diabetes Care Announces Development Agreement with Dexcom for Integration of Future Generation CGM Systems 3TPI Provides Update Regarding Non-Compliance with NYSE MKT Continued Listing Requirements 2
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced ... private company that holds certain rights and know-how to poloxamer-based ... the target company. About the ... target company contemplate an all-stock acquisition by merger. Other than ...
... 2011 Amarin Corporation plc (Nasdaq: AMRN ... focus on cardiovascular disease, today announced that, in connection ... Depositary Shares ("ADSs"), the underwriters of the offering have ... an aggregate of 1,800,000 additional ADSs to cover over-allotments. ...
Cached Medicine Technology:ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 2ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 3ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 4ADVENTRX Announces Signing of Term Sheet for Acquisition of Poloxamer-Based Therapeutics 5Amarin Announces Underwriters' Exercise of Over-Allotment Option 2Amarin Announces Underwriters' Exercise of Over-Allotment Option 3Amarin Announces Underwriters' Exercise of Over-Allotment Option 4
(Date:7/30/2015)... ... July 30, 2015 , ... World Patent Marketing, a ... app invention that can help people during emergencies. , "The worldwide mobile health ... Creative Director of World Patent Marketing. "Currently, there are about 97,000 mobile health ...
(Date:7/30/2015)... ... 2015 , ... In an effort to provide the twenty four hour continuous ... in his practice. , The decision will also allow him to spend more time ... transferring his in-patient admissions to the hospitalists at East Liverpool City Hospital.Dr. Aggarwal has ...
(Date:7/30/2015)... ... July 30, 2015 , ... In a meaningful ritual intended ... Palms Drug Addiction Treatment Center have created an addiction graveyard. Sharing this with the ... most beloved residents, Rocky Hudson . Hudson (1945-2015) fell in love with the ...
(Date:7/30/2015)... ... 30, 2015 , ... Google recently announced that it will be disclosing any ... in a June 8, 2015 article published by Nasdaq , the powerful tech ... by its computer-driven cars, which such industry players as Tesla CEO Elon Musk believe ...
(Date:7/30/2015)... ... July 30, 2015 , ... 24/7 Care At Home, a ... San Bernardino, recently announced that the Centers for Medicare and Medicaid (CMS) have awarded ... health care providers. 24/7 Care At Home’s agency is one of three top Orange ...
Breaking Medicine News(10 mins):Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 2Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 3Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 4Health News:Emergency Alert Can Be A Rude Awakening Without World Patent Marketings New App Invention, I AM FINE 5Health News:River Valley Physician Dr. Aggarwal is Making Changes to his Practice 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 2Health News:Serenity Palms Honors Rocky Hudson, an Advocate of AA and a Beloved Resident of Palm Springs 3Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 2Health News:New Google Policy on Reporting Driverless Auto Accidents Points Out Growing Complexity of Personal Injury Law in the 21st Century, Says Law Offices of Burg and Brock 3Health News:24/7 Care At Home Earns a 5-Star Rating from the Centers for Medicare and Medicaid (CMS) 2
... women need screening as much as younger ones, , , ... should continue for women older than 50 -- even ... they have a similar level of risk as younger ... there,s little benefit in repeating smear tests in women ...
... As federal policymakers pursue healthcare reform this year, the ... prevention will be critically evaluated. As part of ... North America,s top medical schools will host scientists from ... the area of integrative medicine. The Consortium ...
... genetic study conducted through Mayo Clinic has identified ... European ancestry, according to a recent issue of ... , Research findings indicate that alcohol dependence ... variations associated with this illness remain unknown. Animal ...
... Holistic Addiction Treatment has added the use of Mild Hyperbarics to drug ... Scotland and Russia, mild hyperbarics is not generally associated with drug and ... alcohol treatment and recovery services that meet the needs of the person ... ...
... finds vets at higher risk of aggressive recurrence only ... News) -- U.S. male military veterans exposed to the ... recurrence of prostate cancer, a new study finds. , ... cancerous prostates. Of those, the 206 men who,d been ...
... Health Ministry Official shows programs funded by the Global Fund and President,s ... , ... Washington, DC (PRWEB) April 23, 2009 -- At a Congressional ... discussed the current state of malaria in Rwanda and how ...
Cached Medicine News:Health News:Don't Lower Age for Cervical Cancer Test, Study Urges 2Health News:Advancements in Integrative Medicine Research to Be Evaluated by Scientists From Leading International Academic Health Centers 2Health News:Mayo clinic study finds gene bringing together animal and human research in alcoholism 2Health News:G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab 2Health News:G & G Holistic Addiction Treatment Uses Innovative Use of Oxygen Therapy Which Restores Mind and Body in Drug Rehab 3Health News:Agent Orange Exposure Tied to Prostate Cancer Return 2Health News:A View from Rwanda: Congressional Briefing Highlights Impact of U.S. funded Anti-Malaria Programs 2Health News:A View from Rwanda: Congressional Briefing Highlights Impact of U.S. funded Anti-Malaria Programs 3
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: